Sandbox reserved 392
From Proteopedia
(Difference between revisions)
| Line 5: | Line 5: | ||
This Shows the possibility that the high affinity aminoglycoside complexes may have the capability to acetylate a key biosynthetic intermediate of mycothiol. Mycothiol is a major reducing agent in the myobacteria. If this occurs it may participate in the regulation of cellular redox potential. | This Shows the possibility that the high affinity aminoglycoside complexes may have the capability to acetylate a key biosynthetic intermediate of mycothiol. Mycothiol is a major reducing agent in the myobacteria. If this occurs it may participate in the regulation of cellular redox potential. | ||
| + | |||
| + | Reference: | ||
| + | Vetting, M. W., et al. "Aminoglycoside 2'-N-acetyltransferase from Mycobacterium | ||
| + | tuberculosis-Complex with Coenzyme A and Tobramycin." RCSB Protien Data Base. N.p., 28 Aug. | ||
| + | 2002. Web. 13 July 2011. <http://www.rcsb.org/pdb/explore/explore.do?structureId=1M4D>. | ||
</StructureSection> | </StructureSection> | ||
Revision as of 16:21, 18 September 2012
|
Anything in this section will appear adjacent to the 3D structure and will be scrollable.
Describe the PDB (ligand/protein)
This Shows the possibility that the high affinity aminoglycoside complexes may have the capability to acetylate a key biosynthetic intermediate of mycothiol. Mycothiol is a major reducing agent in the myobacteria. If this occurs it may participate in the regulation of cellular redox potential.
Reference: Vetting, M. W., et al. "Aminoglycoside 2'-N-acetyltransferase from Mycobacterium
tuberculosis-Complex with Coenzyme A and Tobramycin." RCSB Protien Data Base. N.p., 28 Aug.
2002. Web. 13 July 2011. <http://www.rcsb.org/pdb/explore/explore.do?structureId=1M4D>.
</StructureSection>
